Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA:688621)

SHA:688621 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 2, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,131	4,222	7,812	8,192	9,728	-
Market Cap Growth	67.48%	-45.95%	-4.64%	-15.79%	-	-
Enterprise Value	7,017	4,027	7,561	7,889	9,536	-
Last Close Price	65.26	37.59	69.26	72.13	85.40	-
PE Ratio	54.11	23.80	42.28	52.35	92.07	-
Forward PE	31.83	31.74	31.74	41.58	79.34	-
PS Ratio	7.01	3.92	8.38	12.11	19.71	-
PB Ratio	6.12	3.83	7.39	9.02	12.64	-
P/TBV Ratio	6.30	3.95	7.75	9.45	13.28	-
P/FCF Ratio	111.28	2749.41	392.53	89126.79	2953.42	-
P/OCF Ratio	99.61	131.87	84.13	78.80	110.23	-
EV/Sales Ratio	6.90	3.73	8.11	11.66	19.32	-
EV/EBITDA Ratio	39.77	19.96	35.09	45.56	72.53	-
EV/EBIT Ratio	55.88	22.84	39.08	50.53	79.49	-
EV/FCF Ratio	109.49	2621.91	379.91	85835.42	2895.08	-
Debt / Equity Ratio	0.51	0.41	0.42	0.28	0.27	0.12
Debt / EBITDA Ratio	3.34	2.03	1.88	1.32	1.40	0.26
Debt / FCF Ratio	9.18	296.79	22.44	2802.12	62.76	0.65
Asset Turnover	0.47	0.56	0.56	0.50	0.61	1.04
Inventory Turnover	35.28	36.48	29.97	29.56	32.55	34.90
Quick Ratio	1.59	1.80	1.69	1.93	2.15	1.17
Current Ratio	1.80	1.95	1.78	2.01	2.25	1.37
Return on Equity (ROE)	11.29%	15.65%	18.61%	18.91%	22.61%	47.59%
Return on Assets (ROA)	3.66%	5.72%	7.27%	7.21%	9.21%	15.32%
Return on Invested Capital (ROIC)	12.18%	19.62%	27.57%	33.58%	49.08%	91.78%
Return on Capital Employed (ROCE)	10.20%	14.60%	17.60%	16.50%	14.50%	42.60%
Earnings Yield	1.87%	4.20%	2.37%	1.91%	1.09%	-
FCF Yield	0.90%	0.04%	0.26%	0.00%	0.03%	-
Dividend Yield	0.26%	0.43%	0.24%	0.59%	0.22%	-
Payout Ratio	27.83%	21.51%	30.05%	17.24%	1.18%	1.48%
Buyback Yield / Dilution	1.81%	-0.28%	-0.19%	-14.09%	-16.84%	0.19%
Total Shareholder Return	2.06%	0.16%	0.05%	-13.50%	-16.62%	0.19%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.